Premium
Human stem cell‐derived cardiomyocytes for pharmacological and toxicological modeling
Author(s) -
Harding Sian E.
Publication year - 2011
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.2011.06328.x
Subject(s) - stem cell , microbiology and biotechnology , cell , chemistry , pharmacology , computational biology , biology , biochemistry
Cardiomyocytes derived from human pluripotent stem cells have advantages for modeling in terms of phenotype, longevity in culture, ease of transfection, and high‐throughput capability.